Food (Health) Supplement Retailers — NAICS 456191 (United States)

A Histometrics industry primer for public- and private-market investors.

---

1. Overview

This is the business of selling vitamins, minerals, protein powders, herbal products, and other dietary supplements out of dedicated specialty stores and their websites — think GNC (formerly General Nutrition Centers) and The Vitamin Shoppe, plus thousands of independent "vitamin shops" and health-food supplement counters. It is a retail channel, not a manufacturer: these stores buy branded and private-label product and resell it to walk-in and online consumers.

Why it matters: Americans are heavy, habitual supplement buyers. Roughly three-quarters of U.S. adults take a dietary supplement, and users spend a median of about $50 a month on them.[6] Demand is structural (an aging population, preventive-health culture, sports nutrition, the GLP-1 weight-loss wave) and recurring (people re-buy the same bottle monthly). The catch — and the whole investment story here — is that the specialty-store channel covered by this NAICS (North American Industry Classification System) code has been losing share for a decade to mass merchants, warehouse clubs, drugstores, and online marketplaces.

Public vs. private ways in: there is essentially no pure-play U.S.-listed supplement retailer today. The two iconic national chains are both privately held — GNC is owned by a Chinese pharmaceutical group, and The Vitamin Shoppe was bought by private-equity firms in 2025.[20][21][25][26] Public-market investors reach the theme indirectly, through supplement brand makers, diversified grocers, and the mass/online retailers that actually move most of the volume. Private-market investors get the more direct exposure — through PE (private-equity) ownership of the chains, franchising, or venture bets on direct-to-consumer (DTC) brands.

---

2. What it is, and how it's structured

Scope (NAICS 456191 "Food (Health) Supplement Retailers"): establishments primarily engaged in retailing food-supplement products — vitamins, minerals, herbs, nutrition supplements, sports/body-enhancing supplements, protein, probiotics, and gummies.[1] The unifying trait is a store (or store-branded website) whose primary business is supplements. Under the 2017 NAICS this activity sat in code 446191; the 2022 revision renumbered it to 456191, which is the code used here.[2]

What it excludes — important, because most supplement dollars are spent outside this code:

• Pharmacies and drug retailers (NAICS 456110) — CVS, Walgreens, and other drugstores that sell supplements alongside prescriptions.[1]
• Cosmetics/beauty retailers (456120) and optical-goods retailers (456130) — adjacent health-and-personal-care specialty codes.[1]
• Food and beverage retailers (NAICS subsector 445) — supermarkets and natural-grocery chains (e.g., Natural Grocers, Sprouts) whose primary business is groceries even when they carry deep supplement sets.[1]
• General-merchandise / warehouse clubs and supercenters (NAICS subsector 455) — Walmart, Target, Costco.
• Electronic shopping / mail-order (NAICS 4541) — pure online sellers such as Amazon, iHerb, and Vitacost sit here, not in 456191.
• Direct sellers / multi-level marketers (MLMs) — Herbalife, USANA, Nature's Sunshine and similar network-marketing supplement companies are classified as direct-selling, not store retail. Large supplement brands are typically classified as manufacturers or wholesalers.

Ownership mix. The industry is a barbell: two national chains (GNC, The Vitamin Shoppe) plus a very long tail of small independents and franchisees. GNC alone runs roughly 2,300 U.S. locations, of which about 800 are independently owned franchises rather than corporate stores.[23] That franchise structure means many "establishments" in the federal count are small, individually owned businesses. Federal concentration data confirm the fragmentation (Section 3).

---

3. How big it is

Our ground-truth federal figures for NAICS 456191:

Read on concentration: an HHI (a standard 0–10,000 market-concentration score) of 167 is very low — anything under 1,500 is considered "unconcentrated" by U.S. antitrust agencies. With the top four firms at just 21.5% of sales and 8,000-plus firms in total, this is a fragmented industry with a large small-operator/franchise tail, not a two-company oligopoly. The SBA (Small Business Administration) $22.5M figure is a program-eligibility threshold, not an estimate of typical retailer size.

The undercount caveat — this code captures only one channel, one way. Two limits apply. First, CBP counts only businesses with paid employees, so nonemployer, solo, and home-based operators (and some online sellers) are missing or classified elsewhere — a real gap in a tiny-operator-heavy trade. Second, and larger: the $21.6 billion of specialty-store receipts is a fraction of what Americans spend on supplements. Total U.S. dietary-supplement sales are estimated at roughly $60–73 billion; one 2024 industry tally (Nutrition Business Journal, via Nutraceuticals World) put it near $72.9 billion.[7] The difference sits in the excluded channels above: mass merchants, warehouse clubs, drugstores, grocery, online marketplaces, and direct sellers. Specialty stores are still the single largest store-type channel in North America (about 46% of the category by one estimate),[8] but online is the fastest-growing. So NAICS 456191 is best read as the specialty brick-and-mortar slice of a much larger supplement economy — roughly a quarter to a third of total supplement retail spend — not the whole industry. (A broader private tally, First Research, counts ~11,000 establishments and ~$21 billion using a wider definition;[9] our federal figures are narrower and preferred here.)

The federal file carries no industry-wide same-store sales, online-sales share, gross margin, inventory-turn, or retention data — those cannot be inferred from the receipts total and are not asserted here.

---

4. The investable universe

Bottom line: there is no pure-play, U.S.-listed supplement retailer to buy. Both national chains are private, and the biggest online players are private or divisions of larger companies. Public-market exposure is indirect. The cleanest way to organize the universe is by how directly each name touches supplement retail. (Company figures below are from the most recent SEC — Securities and Exchange Commission — filings; supplement revenue is rarely broken out.)

A. Diversified / specialty retailers with real supplement-retail exposure (public)

B. Supplement brand and nutrition makers (public) — they make what these stores sell

C. The direct specialty-retail layer is private / other-owned

The federal statistics do not provide a complete ownership census of private chains, franchisees, brands, or nonemployer businesses.

---

5. How the money works

Supplement retail is a high-gross-margin, small-box, repeat-purchase business: the retailer buys finished product from brands, distributors, or contract manufacturers and earns the spread between selling price and product cost. The levers that matter:

• Gross margin and private label. Supplements carry high gross margins; branded product is lower-margin and its price is easy to compare online, so the chains push their own private-label lines (GNC-branded, Vitamin Shoppe-branded), which can carry substantially higher margins and build loyalty. Mix-shift toward private label is the single biggest margin lever — but it also concentrates product-liability and quality-control risk on the retailer.[29]
• Comparable-store (same-store) sales — the core retail health metric: how much a store open at least a year grows year-over-year. Positive comps signal the format still works; multi-year weakness in mall-based comps is exactly why both chains restructured. Natural Grocers and Sprouts both flag comparable sales, transaction counts, average ticket, inventory/shrink, and occupancy as key operating measures.[12][13]
• Unit economics. A typical store is a small (~1,500–2,000 sq ft) strip-mall or mall unit. Fixed occupancy costs create operating leverage when sales rise and cost deleverage when traffic falls; profit hinges on foot traffic, average basket size, and rent as a share of sales — GNC's historical over-exposure to expensive mall leases was a key reason it faltered.
• Franchising = capital-light revenue. GNC franchises ~800 U.S. units, earning franchise royalties plus wholesale product sales to franchisees, with the franchisee carrying rent and labor. A GNC franchise has reported median gross revenue around $444,000 per unit.[24] For the franchisor this is a higher-return, lower-capital model than owning stores.
• Loyalty and subscription/auto-ship. Recurring "subscribe-and-save" auto-ship converts a discretionary purchase into predictable, higher-retention revenue and is central to the online model.
• Wholesale/mass distribution and inventory. Chains and brands also sell into Walmart/Amazon (high volume, low margin, reach). Thousands of SKUs, expiration dating, and shrink management drive working capital and markdowns.

Direct-selling economics differ and are not directly comparable to store retail: those companies source or make product, then pay commissions to independent distributors — their reported sales and margins reflect a different model.

---

6. What drives demand

• Broad, habitual usage. ~75% of U.S. adults use supplements, a rate that has held at high levels; users skew brand-loyal and prefer supplements to over-the-counter or prescription drugs where possible.[6]
• Aging + preventive-health culture. Older consumers buy more; the wider "wellness"/self-care movement expands the buyer base and basket.
• Specialty-ingredient cycles. Categories rise and fall fast: magnesium usage jumped to 23% of users (2024) from 19% (2023), melatonin to 16% (from 10% in 2020), and ashwagandha to 8% (from 2% in 2020); personalization is a stated priority for ~69% of buyers.[6]
• Sports nutrition and protein. Protein and creatine are durable growth engines; creatine dollar sales grew sharply (up ~72% in the multi-outlet channel by one read). BellRing cites protein awareness, snacking, and on-the-go consumption as category drivers.[10][18]
• The GLP-1 weight-loss wave. GLP-1 (glucagon-like peptide-1) drugs — the Ozempic/Wegovy class — are a two-sided force. Users lose muscle as well as fat, driving demand for protein, creatine, and "GLP-1 companion" supplements — a GLP-1 nutritional-support niche projected to grow from ~$4.1B (2025) to ~$13B (2035).[11] But appetite suppression can dent some snack-adjacent and legacy weight-loss categories.
• Digital discovery. Social-commerce and influencers now drive much of what sells, accelerating category fads and shifting share online.
• Discretionary-spending sensitivity. Basic vitamins are relatively resilient (a "self-care" staple); premium sports-nutrition, beauty, weight-management, and novelty products are more discretionary, and consumers trade down to private label or cheaper channels when budgets tighten.

---

7. Regulation

Supplements sit in a distinctive, relatively light regulatory regime — a core part of the investment thesis and its main risk.

• DSHEA (Dietary Supplement Health and Education Act, 1994). The foundational law, which amended the Federal Food, Drug, and Cosmetic Act. Supplements are regulated as food, not drugs: the FDA (Food and Drug Administration) does not pre-approve them for safety, effectiveness, or labeling; the company is responsible for safety and compliance before sale, with the FDA handling post-market oversight.[32][34]
• Structure/function claims. Labels may say a product "supports immune health" but cannot claim to diagnose, treat, cure, or prevent disease (that's drug territory). Such claims must carry the FDA-not-evaluated disclaimer and be notified to FDA.[33]
• New Dietary Ingredient (NDI) notifications must be filed with FDA at least ~75 days before marketing a genuinely new ingredient, and manufacturing must follow current Good Manufacturing Practices (cGMP, 21 CFR Part 111).[34][35]
• Advertising is policed by the FTC (Federal Trade Commission), which requires health claims to be truthful and backed by competent, reliable scientific evidence — a standard that reaches websites, influencers, testimonials, and distributor claims.[38]
• State layer. California's Prop 65 warnings apply; several states (New York, California) have moved to restrict sales of certain weight-loss/diet supplements to minors — a retailer compliance burden.
• The 2025–26 wildcard: MAHA / RFK Jr. Under the "Make America Healthy Again" agenda, with Robert F. Kennedy Jr. as HHS (Health and Human Services) Secretary, the administration is broadly supplement-friendly but is also pushing DSHEA "modernization" — including talk of a mandatory product listing (MPL) requirement, tighter ingredient oversight, and reform of the self-affirmed GRAS ("generally recognized as safe") pathway.[39] In a December 2025 industry letter, FDA said it was considering changes to DSHEA disclaimer placement and would exercise enforcement discretion meanwhile — a policy-development risk, not yet a final rule.[36][37] For retailers this cuts both ways: a higher-trust, better-regulated category could support pricing and premium brands, while new listing/testing costs and possible ingredient restrictions raise compliance overhead.
• Ownership scrutiny. GNC's Chinese state-linked ownership has drawn political attention — including 2025 legislation proposed to bar GNC from U.S. military bases.[22]

---

8. Competitive dynamics & consolidation

• Fragmented and channel-pressured. Federal data show low concentration (CR4 21.5%, HHI 167).[4] The competitive threat isn't a dominant rival within the code — it's the channels outside it: Amazon and iHerb online, Costco and Walmart on price, drugstores and grocers on convenience, and DTC brands going straight to the consumer. Entry is cheap for a basic online assortment, but scale matters in sourcing, fulfillment, quality systems, data, and private label. The highest-volume supplement sales now run through supermarkets/superstores and online, not specialty stores.[9]
• A decade of structural decline for the specialty box. Both national chains passed through distress: GNC filed Chapter 11 in 2020 (owing ~$895M) and emerged under Harbin ownership;[22] The Vitamin Shoppe ended up inside Franchise Group, which itself filed Chapter 11 in late 2024 (~$2B debt) and sold the chain to PE in 2025.[25][27] The lesson: too many high-rent mall leases against a commoditized, price-transparent product.
• Consolidation is happening at the edges, not the center. Online is consolidating — iHerb bought Vitacost from Kroger (2026), combining two of the largest online supplement retailers.[28] PE is re-tooling the brick-and-mortar chains (Kingswood/PIP at Vitamin Shoppe). Brand-side M&A is active: Nestlé completed a $5.75B acquisition of core Bountiful Company brands in 2021 (Nature's Bounty, Solgar, Osteo Bi-Flex, Puritan's Pride, Ester-C, Sundown), and deals continue in sports nutrition and DTC.[31] Concentration is thus more visible in branded product and chain ownership than in national retail market share.
• How survivors compete. Private-label margin, expert in-store service and curation, loyalty/auto-ship, omnichannel (buy-online/pick-up-in-store), and franchising for asset-light expansion. Sponsor-backed owners can fund those upgrades — but leverage magnifies execution and refinancing risk.

---

9. Risks

• Channel disintermediation. The structural risk. Amazon, iHerb, Costco, Walmart, and DTC brands can undercut specialty stores on price and convenience; the format's share has been eroding for years.
• Product safety, adulteration, and liability. Supplements periodically face contamination, spiked "sports/sexual-enhancement" products, mislabeling, and recall/reputational events — and the retailer can be exposed even when manufacturing is outsourced.
• Regulatory tightening. DSHEA modernization, a mandatory product listing, GRAS reform, ingredient bans, or aggressive claims enforcement would raise costs and could pull popular SKUs.[36][39]
• Supply chain and input costs. Heavy reliance on imported raw materials (much vitamin/ingredient production is concentrated in China) exposes margins to tariffs, freight, and geopolitical disruption; cyber and logistics failures add tail risk.
• Fad/category concentration and inventory. Fast-cycling ingredients mean today's growth engine (ashwagandha, GLP-1 companions) can fade; misjudging inventory leads to markdowns and dated-product write-offs.
• Discretionary spending. Semi-discretionary demand softens and trades down in a downturn.
• Real estate. Brick-and-mortar operators carry lease exposure; the mall-format legacy remains a drag.
• GLP-1 is double-edged. A tailwind for protein/muscle-preservation but a potential headwind for appetite-driven and legacy weight-loss categories.
• Direct-selling risk (for the MLM proxies). Distributor conduct, earnings claims, and compensation-plan design create added FTC and state-regulatory exposure.[38]
• Private-company opacity and political risk. GNC and The Vitamin Shoppe disclose far less than listed firms, so buyers must diligence debt, leases, store-level profitability, inventory, and covenants; foreign-state ownership of GNC also invites recurring policy scrutiny.[22]

---

10. How to invest, and the outlook

Public-market routes (all indirect — no pure-play retailer exists), in four buckets:

1. Specialty-retail proxies: Natural Grocers (NGVC) is the closest listed proxy for supplement-heavy specialty retail; Sprouts (SFM) is a lighter version — adjust for their grocery mix.[12][13]
2. Direct selling / DTC: Herbalife (HLF), USANA (USNA), Nature's Sunshine (NATR), LifeVantage (LFVN), Medifast (MED) — the most concentrated supplement-demand exposure on public markets, but with direct-selling regulatory risk.
3. Brands / upstream nutrition: BellRing (BRBR), Simply Good Foods (SMPL), Glanbia (GLB) — own the product, not the store.
4. Distribution channels that win the volume shift: Amazon (AMZN), Costco (COST), Walmart (WMT) — supplements are a small slice of each.

Compare names using comparable-store sales, transaction growth, average ticket, gross margin, inventory turns, private-label share, digital repeat rates, rent, leverage, and free cash flow. For valuation, apply price-to-sales or EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation, and amortization) only after adjusting for geographic mix, direct-selling exposure, and the share of revenue actually tied to supplements.

Private-market routes (the direct exposure):

• Private equity is the way to own the specialty-retail layer — The Vitamin Shoppe (Kingswood/PIP) and GNC (Harbin) sit here, alongside PE-backed iHerb; also upstream in private-label manufacturing (e.g., IVC).[25][28]
• Franchising — operating a GNC franchise is a direct small-business route (median unit revenue ~$444K).[24]
• Venture/angel — the most active growth area is DTC and personalized/subscription supplement brands.

Private buyers should underwrite store-level cash flow, lease obligations, product-quality and regulatory files, supplier concentration, aged inventory, customer-acquisition cost, repeat-purchase rates, private-label economics, and debt service.

Outlook (forward-looking judgment). Underlying U.S. supplement demand looks structurally healthy — high, sticky usage; aging demographics; and the GLP-1 protein tailwind point to continued modest, mid-to-high-single-digit category growth.[7][11] But the specialty-store channel this NAICS code measures is likely to keep ceding share to online and mass channels; value should accrue to omnichannel operators with strong private label, loyalty/auto-ship, and franchise leverage rather than to legacy mall boxes. Near-term catalysts to watch: (1) the shape of MAHA/DSHEA regulatory reform, which could reset the category's trust and cost structure; (2) further online consolidation and pricing after the iHerb–Vitacost tie-up (and any eventual iHerb IPO); and (3) how durably the GLP-1 wave converts into protein, creatine, and muscle-preservation sales. The federal data contain no official forecast, so no specific growth rate is asserted. For most public investors the practical exposure is a brand maker or a diversified retailer; direct ownership of a supplement store remains a private-market or franchising decision.

---

Sources

1. U.S. Census Bureau, "2022 NAICS — 456191 Food (Health) Supplement Retailers (definition and exclusions)." https://www.census.gov/naics/?details=456191&year=2022
2. U.S. Bureau of Labor Statistics, "2022 NAICS Revision and Crosswalk" (446191 → 456191). https://www.bls.gov/ces/naics/naics-2022.htm
3. U.S. Census Bureau, County Business Patterns (CBP), NAICS 456191, 2023 (establishments, employment, annual and first-quarter payroll). https://www.census.gov/programs-surveys/cbp.html
4. U.S. Census Bureau, 2022 Economic Census — Concentration of Sales by Largest Firms, NAICS 456191 (firms, receipts, CR4/CR8/CR20/CR50, HHI). https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN
5. U.S. Small Business Administration, "Table of Size Standards," NAICS 456191, 2023. https://www.sba.gov/document/support-table-size-standards
6. Council for Responsible Nutrition / Ipsos, "2024 CRN Consumer Survey: 75% of Americans use supplements," 2024. https://www.nutraingredients.com/Article/2024/11/07/2024-CRN-Consumer-Survey-75-of-Americans-use-supplements/
7. Nutraceuticals World, "U.S. Supplement Sales Hit $72.88 Billion…," 2024 (Nutrition Business Journal data). https://www.nutraceuticalsworld.com/exclusives/u-s-supplement-sales-hit-72-88-billion-as-sports-nutrition-and-digital-discovery-drive-growth/
8. Mordor Intelligence / Grand View Research, "North America Dietary Supplement Market — specialty stores ~46% channel share," 2024. https://www.mordorintelligence.com/industry-reports/north-america-dietary-supplement-market
9. First Research, "Health Supplement Stores — Industry Profile" (~11,000 establishments; ~$21B; channel competition), 2024. https://www.firstresearch.com/Industry-Research/Health-Supplement-Stores.html
10. Nutritional Outlook, "Why creatine and protein continue to see significant sales growth," 2025. https://www.nutritionaloutlook.com/view/why-creatine-and-protein-continue-to-see-significant-sales-growth-in-the-nutraceutical-space
11. Future Market Insights, "GLP-1 Nutritional Support Market Size & Share 2025–2035," 2025. https://www.futuremarketinsights.com/reports/glp-1-nutritional-support-market
12. U.S. SEC, Natural Grocers by Vitamin Cottage 2025 Form 10-K (net sales ~$1.33B, net income ~$46.4M, 168 stores/21 states, comps +7.3%, gross margin 29.9%). https://www.sec.gov/Archives/edgar/data/1547459/000143774925037556/ngvc20250930_10k.htm
13. U.S. SEC, Sprouts Farmers Market 2025 Form 10-K (gross margin ~38.8%; operating measures). https://www.sec.gov/Archives/edgar/data/1575515/000157551526000008/sfm-20251228.htm
14. U.S. SEC, USANA Health Sciences 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm
15. U.S. SEC, Nature's Sunshine Products 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/275053/000162828026016540/natr-20251231.htm
16. Herbalife, 2025 Annual Report / Form 10-K. https://ir.herbalife.com/sec-filings
17. U.S. SEC, LifeVantage 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/849146/000084914625000068/lfvn-20250630.htm
18. U.S. SEC, BellRing Brands 2025 Form 10-K (protein, snacking, GLP-1 category trends). https://www.sec.gov/Archives/edgar/data/1772016/000177201625000153/brbr-20250930.htm
19. U.S. SEC, selected 2025–2026 annual reports: Walmart, Costco, Amazon, CVS Health (channel exposure; supplement revenue not separately disclosed). https://www.sec.gov/cgi-bin/browse-edgar
20. McCarthy Tétrault, "Harbin Pharmaceutical's ~US$760–770M agreement to acquire GNC approved by bankruptcy court," 2020. https://www.mccarthy.ca/en/experience/harbin-pharmaceutical-s-us-760m-agreement-to-acquire-gnc-approved-by-bankruptcy-court
21. U.S. SEC, GNC Holdings Form 8-K — completion of acquisition by Harbin (via ZT Biopharmaceutical LLC), 2020. https://www.sec.gov/Archives/edgar/data/1502034/000119312520265653/d25873d8k.htm
22. Wikipedia, "GNC (company)" (Chapter 11, ~$895M debt, Harbin ownership, military-base bill), 2025. https://en.wikipedia.org/wiki/GNC_(company)
23. Sharpsheets, "GNC Franchise FDD, Profits & Costs (2025)" (~2,300 U.S. locations, ~800 franchised). https://sharpsheets.io/blog/gnc-franchise-costs-profits/
24. FranchiseVS, "GNC" franchise profile (median unit revenue ~$444K), 2025. https://franchisevs.com/franchise/gnc/
25. Retail Dive, "The Vitamin Shoppe to be sold to private equity for nearly $195M" (~$193.5M; Kingswood/PIP), 2025. https://www.retaildive.com/news/the-vitamin-shoppe-private-equity-kingswood-capital-acquisition/745742/
26. Kingswood Capital Management / The Vitamin Shoppe, "…Complete Acquisition of The Vitamin Shoppe" (~635 stores; ~700 brand partners), May 2025. https://press.vitaminshoppe.com/2025-05-20-Kingswood-Capital-Management-and-Performance-Investment-Partners-Complete-Acquisition-of-The-Vitamin-Shoppe-R/
27. Retail Dive, "Vitamin Shoppe owner files for bankruptcy" (Franchise Group Chapter 11, ~$2B debt), 2024. https://www.retaildive.com/news/vitamin-shoppe-owner-files-bankruptcy-franchise-group/731857/
28. iHerb, "iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger" (>$2.4B 2024 net sales; completed Jan 2026). https://www.iherb.com/pressreleases/iherb-acquires-vitacost-business/2280
29. Retail Dive, "GNC turns to private labels for growth amid turnaround," 2018. https://www.retaildive.com/news/gnc-turns-to-private-labels-for-growth-amid-turnaround/528771/
30. International Vitamin Corporation, "Private Label Supplement Manufacturing," 2026. https://ivcinc.com/private-label-program/
31. Nestlé, "Nestlé to acquire core brands of The Bountiful Company" ($5.75B), 2021. https://www.nestle.com/media/pressreleases/allpressreleases/nestle-acquire-core-brands-the-bountiful-company-health-nutrition-portfolio
32. Council for Responsible Nutrition, "Dietary Supplement Health & Education Act (DSHEA)," 1994. https://www.crnusa.org/regulation-legislation/fda-ftc-regulations/dietary-supplement-health-education-act-dshea
33. U.S. Food and Drug Administration, "Structure/Function Claims," 2024. https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/structurefunction-claims
34. U.S. Food and Drug Administration, "Questions and Answers on Dietary Supplements" (no pre-approval; NDI 75-day notification). https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
35. U.S. Food and Drug Administration, "Small Entity Compliance Guide: cGMP for Dietary Supplements (21 CFR Part 111)." https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practice-manufacturing-packaging-labeling
36. U.S. Food and Drug Administration, "Letter to the Dietary Supplement Industry on the DSHEA Disclaimer," Dec 2025. https://www.fda.gov/food/information-industry-dietary-supplements/letter-dietary-supplement-industry-dshea-disclaimer
37. Consumer Healthcare Products Association, "CHPA Urges Continued Modernization as FDA Signals Update to DSHEA Labeling Requirements," 2025. https://www.chpa.org/news/2025/12/chpa-urges-continued-modernization-fda-signals-update-dshea-labeling-requirements
38. Federal Trade Commission, "Health Products Compliance Guidance," 2022. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
39. SupplySide SJ, "RFK Jr.'s HHS showing mixed signals for dietary supplement sector" (MPL, GRAS reform), 2025. https://www.supplysidesj.com/supplement-regulations/rfk-jr-s-hhs-showing-mixed-signals-for-dietary-supplement-sector